PRASCEND Controls the Clinical Signs Associated With PPID
PRASCEND Controls the Clinical Signs Associated With PPID1
Pituitary pars intermedia dysfunction (PPID) is one of the most common equine endocrine disorders — but the clinical signs associated with PPID can be controlled with daily treatment. PRASCEND controls the clinical signs of PPID to improve the quality of life of the horse.2
The Most Proven Treatment for PPID
PRASCEND is the most proven treatment available to control the clinical signs associated with PPID in horses.1 The rectangular, half-scored pink tablets contain 1 mg pergolide as pergolide mesylate and are packaged in blister packs.
DESCRIPTION & INDICATION
PRASCEND tablets are rectangular, pink, half-scored tablets containing 1 mg pergolide, as pergolide mesylate, a dopamine receptor agonist for oral use in horses only. It’s used for the control of clinical signs associated with PPID in horses. PRASCEND tablets should not be crushed due to the potential for increased human exposure. PRASCEND has not been evaluated in breeding, pregnant or lactating horses.
3 Reasons to choose PRASCEND1
CONTROLLED SIGNS - improved clinical signs within 3 months and continued through 6 months
PROVEN SUCCESS - 3 out of 4 horses evaluated were considered treatment successes
CLEAR IMPROVEMENT - Hypertrichosis (delayed shedding) improved in 89% of treated horses within 6 months
PRASCEND is a restricted veterinary medicine and must be prescribed by your veterinarian. Any questions regarding your horse or pony should be directed to your veterinary clinic.
1. PRASCEND [Freedom of Information Summary]. St Joseph, MO: Boehringer Ingelheim Vetmedica, Inc.; 2016
2. McFarlane D. equine pituitary pars intermedia dysfunction. Vet Clin North Am Equine Pract. 2011;27(1):93–113.